The Gene Editing Therapeutics Market is undergoing unprecedented growth, driven by breakthroughs in biotechnology and increasing approvals for therapies targeting rare and inherited genetic disorders. Valued at USD 11.13 million in 2024, the market is projected to expand at an extraordinary CAGR of 147.20% from 2025 to 2032, highlighting its potential to reshape the future of medicine....